NeuExcell Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.5M
- Investors
-
10
NeuExcell Therapeutics General Information
Description
Developer of a gene therapy designed to treat neurodegenerative diseases and neural injuries. The company's brain repair technology utilizes in vivo astrocyte-to-neuron conversion by introducing neural transcription factors through adeno-associated virus-based gene therapy, enabling clinicians to restore damaged tissue.
Contact Information
Website
www.neuexcell.comCorporate Office
- 401 North Broad Street
- Suite M125
- Philadelphia, PA 19108
- United States
Corporate Office
- 401 North Broad Street
- Suite M125
- Philadelphia, PA 19108
- United States
NeuExcell Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 04-May-2023 | $14.5M | Completed | Clinical Trials - Phase 1 | ||
| 4. Later Stage VC | Cancelled | Pre-Clinical Trials | ||||
| 3. Later Stage VC | 18-Aug-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 31-Jul-2020 | $6.5M | $7.35M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 23-May-2016 | $850K | $850K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuExcell Therapeutics Comparisons
Industry
Financing
Details
NeuExcell Therapeutics Competitors (3)
One of NeuExcell Therapeutics’s 3 competitors is Taysha Gene Therapies, a Formerly VC-backed company based in Dallas, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Taysha Gene Therapies | Formerly VC-backed | Dallas, TX | ||||
| Mogrify | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Tenaya Therapeutics | Formerly VC-backed | South San Francisco, CA |
NeuExcell Therapeutics Patents
NeuExcell Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026114267-A1 | Compositions and methods for treating alzheimer's disease in primates | Pending | 29-Nov-2024 | ||
| AU-2024391760-A1 | Compositions and methods for treating stroke in primates | Pending | 29-Nov-2023 | ||
| EP-4816387-A1 | Compositions and methods for treating stroke in primates | Pending | 29-Nov-2023 | ||
| WO-2025113676-A1 | Compositions and methods for treating stroke in primates | Inactive | 29-Nov-2023 | ||
| AU-2024386366-A1 | Gene therapy compositions and methods for treating glioma | Pending | 23-Nov-2023 | C12N15/86 |
NeuExcell Therapeutics Signals
NeuExcell Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fujian Haixi Pharma | Corporation | Minority | ||
| Guangzhou Jinkong Fund | Asset Manager | Minority | ||
| Jiangxi Jilinxinsheng Enterprise Management | Corporation | Minority | ||
| Suzhou Guofa Venture Capital | Venture Capital | Minority | ||
| Triwise Capital | Venture Capital | Minority |
NeuExcell Therapeutics FAQs
-
When was NeuExcell Therapeutics founded?
NeuExcell Therapeutics was founded in 2016.
-
Where is NeuExcell Therapeutics headquartered?
NeuExcell Therapeutics is headquartered in Philadelphia, PA.
-
What is the size of NeuExcell Therapeutics?
NeuExcell Therapeutics has 11 total employees.
-
What industry is NeuExcell Therapeutics in?
NeuExcell Therapeutics’s primary industry is Drug Discovery.
-
Is NeuExcell Therapeutics a private or public company?
NeuExcell Therapeutics is a Private company.
-
What is NeuExcell Therapeutics’s current revenue?
The current revenue for NeuExcell Therapeutics is .
-
How much funding has NeuExcell Therapeutics raised over time?
NeuExcell Therapeutics has raised $34.8M.
-
Who are NeuExcell Therapeutics’s investors?
Fujian Haixi Pharma, Guangzhou Jinkong Fund, Jiangxi Jilinxinsheng Enterprise Management, Suzhou Guofa Venture Capital, and Triwise Capital are 5 of 10 investors who have invested in NeuExcell Therapeutics.
-
Who are NeuExcell Therapeutics’s competitors?
Taysha Gene Therapies, Mogrify, and Tenaya Therapeutics are competitors of NeuExcell Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process